Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 1
1993 1
1994 1
1995 1
1996 2
1997 1
1998 2
1999 1
2000 1
2001 5
2002 4
2003 7
2004 4
2005 6
2006 4
2007 8
2008 10
2009 8
2010 3
2011 6
2012 16
2013 19
2014 12
2015 12
2016 8
2017 7
2018 4
2019 12
2020 13
2021 11
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Results by year
Filters applied: . Clear all
Page 1
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA).
Ratni H, Ebeling M, Baird J, Bendels S, Bylund J, Chen KS, Denk N, Feng Z, Green L, Guerard M, Jablonski P, Jacobsen B, Khwaja O, Kletzl H, Ko CP, Kustermann S, Marquet A, Metzger F, Mueller B, Naryshkin NA, Paushkin SV, Pinard E, Poirier A, Reutlinger M, Weetall M, Zeller A, Zhao X, Mueller L. Ratni H, et al. Among authors: bylund j. J Med Chem. 2018 Aug 9;61(15):6501-6517. doi: 10.1021/acs.jmedchem.8b00741. Epub 2018 Jul 25. J Med Chem. 2018. PMID: 30044619
Authors' Reply.
Harris AM, Ziemba J, Bylund J. Harris AM, et al. Among authors: bylund j. Urology. 2020 Apr;138:29. doi: 10.1016/j.urology.2019.11.061. Urology. 2020. PMID: 32252953 No abstract available.
Novel L-nucleoside analogue, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia.
Bankar A, Siriwardena TP, Rizoska B, Rydergård C, Kylefjord H, Rraklli V, Eneroth A, Pinho P, Norin S, Bylund J, Moses S, Bethell R, Kavanagh S, Maclean N, Gronda M, Wang X, Hurren R, Minden MD, Targett-Adams P, Schimmer AD, Albertella M. Bankar A, et al. Among authors: bylund j. Haematologica. 2021 Feb 1;106(2):574-579. doi: 10.3324/haematol.2019.226795. Haematologica. 2021. PMID: 31857370 Free PMC article. No abstract available.
Reply to Julia Volkmann and Sibylle von Vietinghoff.
Dahlstrand Rudin A, Bylund J. Dahlstrand Rudin A, et al. Among authors: bylund j. J Leukoc Biol. 2020 Dec;108(6):1709-1710. doi: 10.1002/JLB.3LT0720-456. Epub 2020 Aug 6. J Leukoc Biol. 2020. PMID: 32767377 No abstract available.
Hyper-truncated Asn355- and Asn391-glycans modulate the activity of neutrophil granule myeloperoxidase.
Tjondro HC, Ugonotti J, Kawahara R, Chatterjee S, Loke I, Chen S, Soltermann F, Hinneburg H, Parker BL, Venkatakrishnan V, Dieckmann R, Grant OC, Bylund J, Rodger A, Woods RJ, Karlsson-Bengtsson A, Struwe WB, Thaysen-Andersen M. Tjondro HC, et al. Among authors: bylund j. J Biol Chem. 2021 Jan-Jun;296:100144. doi: 10.1074/jbc.RA120.016342. Epub 2020 Dec 10. J Biol Chem. 2021. PMID: 33273015 Free PMC article.
Porphyromonas gingivalis Produce Neutrophil Specific Chemoattractants Including Short Chain Fatty Acids.
Dahlstrand Rudin A, Khamzeh A, Venkatakrishnan V, Persson T, Gabl M, Savolainen O, Forsman H, Dahlgren C, Christenson K, Bylund J. Dahlstrand Rudin A, et al. Among authors: bylund j. Front Cell Infect Microbiol. 2021 Jan 19;10:620681. doi: 10.3389/fcimb.2020.620681. eCollection 2020. Front Cell Infect Microbiol. 2021. PMID: 33542906 Free PMC article.
Optimizing DMPK Properties: Experiences from a Big Pharma DMPK Department.
Sohlenius-Sternbeck AK, Janson J, Bylund J, Baranczewski P, Breitholtz-Emanuelsson A, Hu Y, Tsoi C, Lindgren A, Gissberg O, Bueters T, Briem S, Juric S, Johansson J, Bergh M, Hoogstraate J. Sohlenius-Sternbeck AK, et al. Among authors: bylund j. Curr Drug Metab. 2016;17(3):253-70. doi: 10.2174/1389200217666151210125637. Curr Drug Metab. 2016. PMID: 26651977 Review.
169 results